市場調查報告書
商品編碼
1561483
2024-2032 年按產品、製程、最終用戶和地區分類的內視鏡再處理市場報告Endoscope Reprocessing Market Report by Product, Process, End User, and Region 2024-2032 |
2023年,全球內視IMARC Group再處理市場規模達22億美元。該市場主要是由微創手術需求的成長以及嚴格的感染控制法規的實施所推動的。此外,後處理設備的快速技術進步、對患者安全意識的增強以及內視鏡檢查程序的普及也進一步促進了市場的成長。
微創手術的需求不斷增加
對微創手術的日益青睞是內視鏡再處理市場成長的主要動力。與傳統手術相比,這些使用內視鏡的手術具有縮短恢復時間、降低感染風險以及減少術後疼痛等優點。根據美國國家生物技術中心公佈的資料,美國每年進行約1,770萬例胃腸(GI)內視鏡手術,佔所有內視鏡手術的68%。胃腸道內視鏡手術後的複合感染率為0.2%,特定手術的複合感染率較高:ERCP為0.8%,非ERCP上消化道內視鏡為0.123%,下消化道內視鏡為0.073%。因此,內視鏡手術的頻率不斷增加,對有效的再處理解決方案以確保內視鏡的安全性和使用壽命提出了更高的需求。
實施嚴格的感染控制規定
根據行業報告,軟性內視鏡後處理失敗與院內感染 (HAI) 相關,這給患者和醫療保健系統帶來了沉重負擔。 HAI 是報告最多的影響患者的不良事件,整個歐洲的盛行率為 6.5%。手術部位感染佔所有 HAI 的 18.3%,對患者的生活品質有負面影響,並增加發病率和死亡率。它們也給醫療保健系統帶來了巨大的財務負擔。在德國,手術部位感染可能導致平均住院時間延長 17.9 天,每位患者的額外醫療費用為 22,905 歐元。因此,世界各地的政府和醫療機構正在實施嚴格的法規來預防院內感染 (HAI)。為了遵守這些法規並避免處罰,醫療機構正在投資先進的內視鏡再處理系統。這可確保內視鏡已徹底清潔、消毒和滅菌,從而降低 HAI 風險並提高病患安全。
後處理設備的技術進步
技術進步極大地推動了內視鏡再處理市場的成長。自動再處理機、增強型消毒劑和複雜的追蹤系統等創新提高了後處理過程的效率和可靠性。這些技術確保內視鏡始終按照高標準進行清潔,降低人為錯誤的風險,並簡化醫療機構的工作流程,使其成為採用和擴展內視鏡再處理解決方案的關鍵因素。例如,2023 年 1 月,軟性機器人儀器的領先開發商 Agilis Robotics 以其專有的內視鏡手術機器人完成了第二輪活體動物測試。結果表明,機器人系統在功效、準確性和安全性方面取得了良好的成果。因此,機器人在內視鏡手術中的日益整合預計將增加執行的手術數量,從而推動市場成長。
IMARC Group提供了每個細分市場的主要趨勢的分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、流程和最終用戶對市場進行了分類。
高水平消毒劑和試紙佔大部分市場佔有率
該報告根據產品提供了詳細的市場細分和分析。這包括高強度消毒劑和試紙、清潔劑和濕紙巾、自動內視鏡清洗機、內視鏡乾燥、儲存和運輸系統等。報導稱,高強度消毒劑和試紙佔了最大的佔有率。
高水準消毒劑和試紙條因其在確保患者安全方面的有效性和效率而正在提高內視鏡再處理的市場價值。這些消毒劑專門設計用於消除廣譜病原體,包括結核分枝桿菌和艱難梭菌等高度抗藥性的生物體。它們的快速作用特性以及與自動洗消機的兼容性使它們成為繁忙的醫療保健環境中的首選。試紙在驗證消毒過程的功效方面發揮著至關重要的作用,可以立即確認消毒劑是否達到最低建議濃度,從而確保符合安全標準並降低感染風險。例如,RAPICIDE 高水準消毒劑是一種基於戊二醛的快速起效、可重複使用的解決方案,適用於自動洗消機中的軟性內視鏡,無需混合或活化。它可以在 DSD-201 等系統中對熱敏感、半關鍵醫療設備進行再處理,在 95°F (35°C) 下接觸 5 分鐘即可去活化 TB、艱難梭菌和 CRE 等病原體。此消毒劑只需沖洗兩次即可提高效率。 RAPICIDE(TM) 測試條可確認戊二醛的最低建議濃度,需要浸入 3 秒並讀取 75 秒。這個例子說明了特定產品如何推動市場對高水準消毒劑和試紙的需求,從而增加內視鏡再處理市場價值。
自動化清潔佔據產業最大佔有率
報告還提供了基於流程的詳細市場細分和分析。這包括手動清潔和自動清潔。報告稱,自動化清潔佔據最大的市場佔有率。
自動化清潔在內視鏡再處理市場中佔據主導地位,因為它能夠確保一致和高水準的消毒,減少與手動清潔相關的人為錯誤風險。自動內視鏡清洗機 (AER) 等自動化系統提供標準化、高效且有效的清潔和消毒流程,這對於病患安全至關重要。這些系統透過最大限度地減少內視鏡再處理所涉及的時間和勞動力來提高醫療機構內的工作流程效率。此外,自動清潔系統專門設計用於適應現代內視鏡的複雜設計,確保徹底淨化並遵守嚴格的監管標準。作為內視鏡再處理市場預測的一部分,預計在技術進步和對可靠、高效的再處理方法的需求不斷成長的推動下,自動化清潔解決方案的日益採用將繼續塑造市場。
例如,2023 年 3 月,HOYA 集團旗下的 PENTAX Medical 因其創新的自動化預清潔解決方案 AquaTYPHOON 獲得了 CE 標誌。該設備與 PlasmaBiotics 合作開發,為內視鏡再處理中的傳統手動預清潔步驟提供了強大的替代方案,有效解決了醫療保健提供者在日常臨床實踐中遇到的衛生挑戰。
醫院和診所是領先的細分市場
該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、門診手術中心等。報告稱,醫院和診所是最大的部分。
內視鏡再處理市場研究報告強調,醫院和診所是市場的主導部分,因為這些設施內進行了大量的內視鏡手術。據業界報告稱,2023年愛爾蘭減肥手術數量將達到219例,大大超過衛生服務執行局(HSE)設定的200例的修訂目標。這標誌著比 2022 年進行的 109 例手術大幅增加。此外,光是戈爾韋大學醫院在 2023 年就進行了 49 例手術,高於前一年的 19 例。
這些設施需要採取嚴格的感染控制措施,以防止院內感染,因此有效的再處理至關重要。經常使用內視鏡的微創手術日益普及,進一步推動了需求。此外,監管要求和指南要求嚴格的再處理方案,以確保病人安全。高程序量、法規遵從性以及感染預防的迫切需求相結合,使醫院和診所成為內視鏡再處理的主要細分市場。
北美市場領先,佔據最大的內視鏡再處理市場佔有率
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,北美是內視鏡再處理的最大區域市場。
北美在內視鏡再處理市場的主導地位可歸因於其先進的醫療基礎設施、慢性病盛行率的增加、嚴格的監管標準以及內視鏡手術的高頻率。例如,美國麻醉醫師協會2024 年發表的一篇文章表明,美國每年進行約610 萬例上消化道內視鏡檢查。大地推動了對內視鏡的需求再處理解決方案。隨著內視鏡手術在診斷和治療方面變得越來越普遍,內視鏡再處理市場前景反映出對有效再處理技術的需求不斷成長。該地區的醫療保健系統配備了先進的技術和方案,可確保有效的內視鏡再處理以預防感染。此外,醫療保健提供者和患者對感染控制意識的提高,以及不斷的技術進步和對患者安全的關注,進一步鞏固了北美在市場上的領先地位。
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
The global endoscope reprocessing market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The market is primarily being driven by the rising demand for minimally invasive surgeries, and the implementation of stringent regulations on infection control. Additionally, rapid technological advancements in reprocessing equipment, growing awareness about patient safety, and the surging prevalence of endoscopy procedures are further contributing to the market growth.
Increasing Demand for Minimally Invasive Surgeries
The rising preference for minimally invasive surgeries is acting as a major driver for the endoscope reprocessing market growth. These procedures, which use endoscopes, offer benefits such as reduced recovery time, lower risk of infection, and less postoperative pain compared to traditional surgeries. According to the data published on National Center for Biotechnology, approximately 17.7 million gastrointestinal (GI) endoscopic procedures are performed annually in the United States, accounting for 68% of all endoscopic procedures. The composite infection rate following GI endoscopic procedures was 0.2%, with higher rates for specific procedures: 0.8% for ERCP, 0.123% for non-ERCP upper GI endoscopies, and 0.073% for lower GI endoscopies. As a result, the frequency of endoscopic procedures is increasing, leading to a higher demand for effective reprocessing solutions to ensure the safety and longevity of endoscopes.
Implementation of Stringent Infection Control Regulations
As per industry reports, failures in reprocessing flexible endoscopes are associated with hospital-acquired infections (HAIs), which place a significant burden on patients and healthcare systems. HAIs are the most reported adverse events affecting patients, with a prevalence of 6.5% across Europe. Surgical site infections, comprising 18.3% of all HAIs, negatively affect patient quality of life and increase morbidity and mortality rates. They also contribute to a significant financial burden on healthcare systems. In Germany, surgical site infections can lead to an average hospital stay extension of 17.9 days and an additional healthcare cost of €22,905 per patient. As a result, governments and healthcare organizations worldwide are implementing stringent regulations to prevent hospital-acquired infections (HAIs). To comply with these regulations and avoid penalties, healthcare facilities are investing in advanced endoscope reprocessing systems. This ensures that endoscopes are thoroughly cleaned, disinfected, and sterilized, thereby reducing the risk of HAIs and improving patient safety.
Technological Advancements in Reprocessing Equipment
Advancements in technologies are significantly driving the endoscope reprocessing market growth. Innovations, such as automated reprocessing machines, enhanced disinfectants, and sophisticated tracking systems, have improved the efficiency and reliability of the reprocessing process. These technologies ensure that endoscopes are consistently cleaned to high standards, reduce the risk of human error, and streamline the workflow in healthcare facilities, making them a critical factor in the adoption and expansion of endoscope reprocessing solutions. For instance, in January 2023, Agilis Robotics, a leading developer of flexible robotic instruments, completed its second round of live animal testing with its proprietary robot for endoscopic surgery. The results demonstrated promising outcomes in terms of efficacy, accuracy, and safety of the robotic system. Consequently, the increasing integration of robotics in endoscopic surgery is expected to boost the number of procedures performed, thereby driving market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, process, and end user.
High-level disinfectants and test strips account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes high-level disinfectants and test strips, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage and transport systems, and others. According to the report, high-level disinfectants and test strips represented the largest segment.
High-level disinfectants and test strips are enhancing the endoscope reprocessing market value due to their effectiveness and efficiency in ensuring patient safety. These disinfectants are specifically designed to eliminate a broad spectrum of pathogens, including highly resistant organisms such as Mycobacterium tuberculosis and Clostridium difficile. Their fast-acting nature and compatibility with automated reprocessors make them a preferred choice in busy healthcare settings. Test strips play a crucial role in validating the efficacy of the disinfection process, providing immediate confirmation that the minimum recommended concentration of the disinfectant is met, thus ensuring compliance with safety standards and reducing the risk of infections. For instance, RAPICIDE high-level disinfectant is a glutaraldehyde-based, fast-acting, reusable solution for flexible endoscopes in automated reprocessors, requiring no mixing or activation. It reprocesses heat-sensitive, semi-critical medical devices in systems like the DSD-201, inactivating pathogens such as TB, C-diff, and CRE with a 5-minute contact time at 95°F (35°C). The disinfectant enhances efficiency with only two rinses needed. RAPICIDE(TM) Test Strips confirm the minimum recommended concentration of glutaraldehyde, requiring a 3-second dip and a 75-second read time. This example illustrates how specific products drive the demand for high-level disinfectants and test strips in the market, thereby increasing the endoscope reprocessing market value.
Automated cleaning holds the largest share of the industry
A detailed breakup and analysis of the market based on the process have also been provided in the report. This includes manual cleaning and automated cleaning. According to the report, automated cleaning accounted for the largest market share.
Automated cleaning dominates the endoscope reprocessing market due to its ability to ensure consistent and high-level disinfection, reducing the risk of human error associated with manual cleaning. Automated systems, such as automated endoscope reprocessors (AERs), provide standardized, efficient, and effective cleaning and disinfecting processes, which are critical for patient safety. These systems enhance workflow efficiency within healthcare facilities by minimizing both the time and labor involved in reprocessing endoscopes. Additionally, automated cleaning systems are specifically designed to accommodate the intricate designs of modern endoscopes, ensuring thorough decontamination and adherence to stringent regulatory standards. As part of the endoscope reprocessing market forecast, it is expected that the growing adoption of automated cleaning solutions will continue to shape the market, driven by advancements in technology and the increasing demand for reliable and efficient reprocessing methods.
For instance, in March 2023, PENTAX Medical, a division of the HOYA Group, was awarded the CE mark for its innovative automated pre-cleaning solution, the AquaTYPHOON. Developed in collaboration with PlasmaBiotics, this device offers a robust alternative to the traditional manual pre-cleaning step in endoscope reprocessing, effectively addressing the hygiene challenges healthcare providers encounter in daily clinical practice.
Hospitals and clinics represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, ambulatory surgery centers, and others. According to the report, hospitals and clinics represented the largest segment.
The endoscope reprocessing market research report highlights that hospitals and clinics are the dominant segment in the market, attributed to the large volume of endoscopic procedures conducted within these facilities. According to industry reports, the number of bariatric surgery procedures in Ireland reached 219 in 2023, significantly surpassing the revised target of 200 set by the Health Service Executive (HSE). This marked a substantial increase from the 109 procedures performed in 2022. These surgeries were conducted at three HSE sites: St Vincent's University Hospital in Dublin, St Michael's Hospital in Dun Laoghaire, and University Hospital Galway. Additionally, University Hospital Galway alone performed 49 surgeries in 2023, up from 19 in the previous year.
These facilities require stringent infection control measures to prevent hospital-acquired infections, making effective reprocessing essential. The increasing prevalence of minimally invasive surgeries, which frequently utilize endoscopes, further drives demand. Additionally, regulatory requirements and guidelines mandate rigorous reprocessing protocols to ensure patient safety. The combination of high procedural volume, regulatory compliance, and the critical need for infection prevention establishes hospitals and clinics as the primary market segment for endoscope reprocessing.
North America leads the market, accounting for the largest endoscope reprocessing market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for endoscope reprocessing.
North America's dominance in the endoscope reprocessing market can be attributed to its advanced healthcare infrastructure, increasing prevalence of chronic diseases, stringent regulatory standards, and high frequency of endoscopic procedures. For example, a 2024 article by the American Society of Anesthesiologists indicates that approximately 6.1 million upper endoscopies are performed annually in the U.S. Furthermore, the CDC reports that around 129 million Americans suffer from at least one major chronic condition, significantly driving the need for endoscope reprocessing solutions. As endoscopic procedures become more common for both diagnostic and therapeutic purposes, the endoscope reprocessing market outlook reflects a growing demand for effective reprocessing technologies. The region's healthcare systems, equipped with sophisticated technologies and protocols, ensure effective endoscope reprocessing to prevent infections. Additionally, heightened awareness of infection control among healthcare providers and patients, along with continuous technological advancements and a focus on patient safety, further solidify North America's leading position in the market.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)